Search Result "Tivozanib"
Tivozanib: A New Hope for Treating Renal Cell Carcinoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 23 Issue: 5 Year: 2023 Page: 562-570
Author(s): Pooja A. Chawla
Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
Journal: Current Signal Transduction Therapy
Volume: 8 Issue: 3 Year: 2013 Page: 219-228
Author(s): Zofia F. Bielecka,Anna M. Czarnecka,Wojciech Solarek,Anna Kornakiewicz,Cezary Szczylik
A Comprehensive Overview of Targeted Therapy in Metastatic Renal Cell Carcinoma
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 7 Year: 2012 Page: 857-872
Author(s): Z. Mihaly,Z. Sztupinszki,P. Surowiak,B. Gyorffy
Tumor Angiogenesis: A Target for Renal Cell Carcinoma Therapy. Current Perspectives and Novel Strategies
Journal: Recent Patents on Biomarkers
Volume: 2 Issue: 2 Year: 2012 Page: 99-106
Author(s): Matteo Santoni,Daniele Minardi,Luciano Burattini,Rami Raquban,Stefano Cascinu,Giovanni Muzzonigro
VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives
Journal: Current Clinical Pharmacology
Volume: 6 Issue: 3 Year: 2011 Page: 164-168
Author(s): Toni K. Choueiri
Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 20 Issue: 18 Year: 2020 Page: 2150-2168
Author(s): Damanpreet K. Lang,Rajwinder Kaur,Rashmi Arora,Balraj Saini,Sandeep Arora
Recent Advances in Small Molecule Inhibitors of VEGFR and EGFR Signaling Pathways
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 1 Year: 2011 Page: 1571-1590
Author(s): Haizhen Zhong, J. Phillip Bowen
Targeted Therapies in the Treatment of Advanced Renal Cell Carcinoma
Ebook: Topics in Anti-Cancer Research
Volume: 1 Year: 2012
Author(s): Emmanuel Seront,Jean-Pascal Machiels
Doi: 10.2174/9781608054787112010008
Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?
Journal: Current Cancer Drug Targets
Volume: 13 Issue: 3 Year: 2013 Page: 313-325
Author(s): Matteo Santoni, Mimma Rizzo, Luciano Burattini, Rossana Berardi, Giacomo Carteni, Stefano Cascinu
N-Heterocycles as Privileged Scaffolds in FDA Approved Different NMEsof 2021: A Review
Journal: Letters in Organic Chemistry
Volume: 20 Issue: 4 Year: 2023 Page: 287-299
Author(s):